Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Head & Heal is stocked at 194 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Queens, Syracuse, and Buffalo. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Head & Heal derived 78.31% of sales from Tincture & Sublingual with a month-over-month increase of 18.37% but a year-over-year decline of 8.27%, while Concentrates held 18.91% share with a 12.63% MoM rise and no YoY baseline reported. Topical contributed 2.55% share after a 1,393.32% YoY surge but contracted 33.50% MoM, and the brand’s average price of $74.61 sat 9.99% below last year alongside a category-average Tincture price of $78.93. In New York Tincture & Sublingual, the brand ranked 2, indicating that October 2026 mix shifts—heavier MoM gains in the core Tincture set versus a sharp MoM pullback in Topicals—imply a re-consolidation around the primary format while opportunistic extensions remain volatile.
The mix pattern implies that Head & Heal is reinforcing a premium-leaning Tincture proposition (78.31% share, rank 2 in New York) even as it trades price down 9.99% YoY to defend volume, and that Concentrates’ 12.63% MoM growth provides incremental headroom without diluting the core. The 1,393.32% YoY surge but 33.50% MoM drop in Topical suggests trial-heavy, promotion-sensitive demand that is not yet a stable pillar, while the 18.37% MoM Tincture rebound against an 8.27% YoY decline indicates regained monthly velocity that can be leveraged to lift overall sales growth of 16.82% YoY.
Competitive Landscape
Head & Heal sits at rank #2 in New York Tincture & Sublingual for October 2026, unchanged from #2 year over year, and steady versus three months prior at #2, while its historical peak was #1 in December 2024; in contrast, Ayrloom holds #1 now and also held #1 a year ago with sales up 3.6% year over year, and Veterans Choice Creations (VCC) moved from #4 to #3 on 32.7% sales growth as Mfny (Marijuana Farms New York) slipped from #3 to #4 with a 34.9% decline; this combination—Head & Heal flat at #2 while the leader edges up and a challenger advances one rank—implies a stable but contested position where incremental share capture is required to reclaim the #1 spot.
Notable Products
Head & Heal’s sales in October 2026 are tightly concentrated in a few tinctures: the top product, Max Strength THC Tincture, accounts for 38.9% and the top 10 items together make up 98.7% of brand sales. With tinctures holding 78.3% of category mix, most of its sales ride on a small set of tincture SKUs.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






